✦ LIBER ✦

Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo

✍ Scribed by Markus Wagner; Martha E. Lopez; Mitch Cahn; Murray Korc

Book ID: 118520542
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 238 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(98)70594-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGF receptor (EGFR) antagonism inhibits

EGF receptor (EGFR) antagonism inhibits pancreatic cancer (PCA) growth in-vitro and in-vivo

✍ Alan Durkin; Timothy J. Yeatman; Alexander Rosemurgy II; Emmanuel E. Zervos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Novel type I fibroblast growth factor re

Novel type I fibroblast growth factor receptor in pancreatic cancer

✍ Martha E. Lopez; Murray Korc 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Fibroblast Growth Factor Receptor Signal

Fibroblast Growth Factor Receptor Signaling Crosstalk in Skeletogenesis

✍ Miraoui, H.; Marie, P. J. 📂 Article 📅 2010 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 870 KB

Parathyroid hormone receptor signaling i

Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo

✍ Yumie Rhee; Nicoletta Bivi; Emily Farrow; Virginia Lezcano; Lilian I. Plotkin; K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 777 KB

Aberrant fibroblast growth factor recept

Aberrant fibroblast growth factor receptor signaling in bladder and other cancers

✍ Christine L. Chaffer; Bonnie Dopheide; Pierre Savagner; Erik W. Thompson; Elizab 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 926 KB

Apigenin suppresses insulin-like growth

Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study

✍ Sanjeev Shukla; Sanjay Gupta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

## Abstract Deregulation of insulin‐like growth factor (IGF)‐I/IGF‐IR signaling has been implicated in the development and progression of prostate cancer. Agents that can suppress the mitogenic activity of the IGF/IGF‐IR growth axis may be of preventive or therapeutic value. We have previously demo